HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Mohamed Rahmani Selected Research
Mohamed Rahmani Research Topics
Disease
39
Leukemia
01/2020 - 01/2002
24
Neoplasms (Cancer)
05/2023 - 10/2005
12
Mitochondrial Diseases (Mitochondrial Disease)
09/2008 - 01/2002
9
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020 - 01/2006
7
Myeloid Leukemia (Leukemia, Myelocytic)
12/2015 - 01/2002
6
Melanoma (Melanoma, Malignant)
01/2019 - 06/2010
5
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
09/2007 - 07/2004
4
Hematologic Neoplasms (Hematological Malignancy)
01/2023 - 11/2003
3
Breast Neoplasms (Breast Cancer)
01/2024 - 11/2009
3
Carcinoma (Carcinomatosis)
06/2010 - 10/2008
2
Neoplasm Metastasis (Metastasis)
01/2024 - 05/2023
2
Adenocarcinoma
12/2021 - 09/2008
2
COVID-19
06/2021 - 01/2021
2
Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2019 - 05/2017
2
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
05/2017 - 09/2014
2
Ataxia Telangiectasia (Louis Bar Syndrome)
09/2015 - 04/2003
2
B-Cell Lymphoma (Lymphoma, B Cell)
07/2014 - 05/2009
2
Pancreatic Neoplasms (Pancreatic Cancer)
08/2009 - 09/2008
2
Multiple Myeloma
06/2005 - 04/2004
1
Hypoxia (Hypoxemia)
01/2024
1
Colorectal Neoplasms (Colorectal Cancer)
12/2021
1
Liver Diseases (Liver Disease)
06/2021
1
Inflammation (Inflammations)
01/2020
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020
Drug/Important Bio-Agent (IBA)
19
Histone Deacetylase Inhibitors
IBA
09/2019 - 07/2002
18
Proteins (Proteins, Gene)
FDA Link
12/2021 - 01/2002
10
Caspases
IBA
02/2013 - 09/2003
9
Imatinib Mesylate (Gleevec)
FDA Link
09/2007 - 01/2002
9
Cytochromes c (Cytochrome c)
IBA
08/2006 - 01/2002
9
Butyric Acid (Butanoic Acid)
IBA
01/2006 - 07/2002
8
Sorafenib (BAY 43-9006)
FDA Link
06/2012 - 10/2005
8
Reactive Oxygen Species (Oxygen Radicals)
IBA
11/2010 - 05/2004
8
Phosphotransferases (Kinase)
IBA
05/2010 - 01/2002
8
Vorinostat
FDA Link
08/2009 - 12/2003
7
Cytokines
IBA
01/2021 - 06/2010
7
Bortezomib (Velcade)
FDA Link
05/2017 - 10/2003
6
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
11/2009 - 09/2003
6
Proteasome Inhibitors
IBA
05/2009 - 10/2003
6
Cyclin-Dependent Kinases (cdk Proteins)
IBA
08/2006 - 04/2003
6
7-hydroxystaurosporine (UCN 01)
IBA
06/2005 - 07/2002
5
Heat-Shock Proteins (Heat-Shock Protein)
IBA
05/2010 - 09/2003
5
tanespimycin (17AAG)
IBA
05/2010 - 09/2003
5
Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
IBA
05/2010 - 01/2002
4
Histone Deacetylases (Histone Deacetylase)
IBA
01/2016 - 11/2003
4
ABT-737
IBA
12/2015 - 05/2011
4
Ceramides
IBA
11/2010 - 03/2005
4
Mitogen-Activated Protein Kinases
IBA
05/2010 - 01/2002
4
2- (2- chloro- 4- iodophenylamino)- N- cyclopropylmethoxy- 3,4- difluorobenzamide
IBA
11/2009 - 01/2002
4
NF-kappa B (NF-kB)
IBA
07/2005 - 09/2003
4
alvocidib (flavopiridol)
IBA
10/2004 - 04/2003
3
Enzymes
IBA
06/2021 - 12/2010
3
RNA (Ribonucleic Acid)
IBA
06/2021 - 01/2020
3
Interleukin-10 (Interleukin 10)
IBA
05/2011 - 06/2010
3
Interleukins
IBA
05/2011 - 06/2010
3
CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)
IBA
08/2009 - 09/2008
3
Caspase 3 (Caspase-3)
IBA
04/2005 - 01/2002
2
belinostat
IBA
05/2017 - 01/2016
2
dactolisib
IBA
09/2014 - 02/2013
2
obatoclax
IBA
06/2012 - 11/2009
2
Peptide Initiation Factors (Initiation Factor)
IBA
12/2010 - 08/2007
2
Small Interfering RNA (siRNA)
IBA
12/2010 - 08/2004
2
Endoplasmic Reticulum Chaperone BiP
IBA
12/2010 - 05/2010
2
geldanamycin
IBA
05/2010 - 09/2008
2
U 0126 (UO 126)
IBA
11/2009 - 04/2003
2
perifosine
IBA
11/2009 - 03/2005
2
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
11/2009 - 04/2003
2
Mitogen-Activated Protein Kinase 3
IBA
11/2009 - 09/2008
2
p38 Mitogen-Activated Protein Kinases
IBA
09/2008 - 04/2003
2
MAP Kinase Kinase 1
IBA
09/2008 - 04/2006
2
src-Family Kinases
IBA
05/2007 - 08/2004
2
NSC 680410
IBA
01/2006 - 02/2004
2
benzyloxycarbonylleucyl-leucyl-leucine aldehyde
IBA
01/2006 - 10/2003
2
Tyrphostins
IBA
01/2006 - 02/2004
2
entinostat (MS 275)
IBA
07/2005 - 04/2004
2
Farnesyltranstransferase (Farnesyltransferase)
IBA
06/2005 - 02/2005
2
Apoptosis Inducing Factor
IBA
04/2005 - 03/2005
2
Sirolimus (Rapamycin)
FDA Link
03/2005 - 04/2003
2
Protein Kinase C
IBA
03/2005 - 09/2003
2
Caspase 8 (Caspase-8)
IBA
02/2005 - 07/2002
2
Antioxidants
IBA
05/2004 - 02/2004
2
Acetylcysteine (Siran)
FDA Link
Generic
05/2004 - 02/2004
2
Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
IBA
04/2004 - 01/2002
2
Proteasome Endopeptidase Complex (Proteasome)
IBA
11/2003 - 10/2003
2
Roscovitine
IBA
10/2003 - 04/2003
2
2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- one
IBA
09/2003 - 04/2003
2
Mitogens
IBA
04/2003 - 01/2002
1
Hypoxanthine
IBA
01/2024
1
Plasminogen Activator Inhibitor 1
IBA
05/2023
1
Human Growth Hormone (Saizen)
FDA Link
Generic
05/2023
1
Proteolysis Targeting Chimera
IBA
01/2023
1
Messenger RNA (mRNA)
IBA
12/2021
1
Biomarkers (Surrogate Marker)
IBA
12/2021
1
Progesterone Receptors (Progesterone Receptor)
IBA
01/2021
1
venetoclax
IBA
01/2020
1
cobimetinib
IBA
01/2020
1
1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)
IBA
01/2019
Therapy/Procedure
5
Therapeutics
01/2024 - 10/2011
1
Colectomy
12/2021
1
Lasers (Laser)
01/2021
1
Immunomodulation
01/2020